Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis
- PMID: 15955139
- DOI: 10.1111/j.1440-1843.2005.00711.x
Levels of tumour necrosis factor-alpha and IL-1alpha in newly diagnosed and multidrug resistant tuberculosis
Abstract
Background: The pro-inflammatory cytokines tumour necrosis factor (TNF)-alpha and IL-1alpha play key roles in host defence against tuberculosis (TB) but there is little knowledge of their levels in multidrug resistant TB (MDR-TB). The aim of the present study was to investigate the levels of TNF-alpha and IL-1alpha and their relationship with the levels of T helper (CD4+), T suppressor (CD8+) and total lymphocytes (CD45+) in newly diagnosed TB (N-TB) and MDR-TB.
Methodology: This study assessed 19 N-TB patients (M/F : 17/2) and 11 MDR-TB patients (M/F : 10/1). Serum TNF-alpha and IL-1alpha were assessed by ELISA. Lymphocyte expression of CD45, CD4, CD8, CD3, CD23, CD19 and CD95 were determined by flow cytometry.
Results: The levels of TNF-alpha, IL-1alpha, and CD4, CD4/CD8, CD45, CD19, CD23 and CD95 positive lymphocytes were lower in MDR-TB than in N-TB patients (P < 0.05). Statistically, there was a positive correlation between TNF-alpha and IL-1alpha (r = 0.92) for both MDR-TB and N-TB. For both groups, both TNF-alpha and IL-1alpha correlated with CD4+ lymphocytes (r = 0.48). TNF-alpha and IL-1alpha showed negative correlations with CD8+ lymphocytes (r = -0.81, r = -0.73) (P < 0.01) in MDR-TB patients.
Conclusion: The lower levels of cytokines and numbers of T helper lymphocytes in MDR-TB compared with N-TB implies that the immune profiles of the two groups are different, and may be important in the natural history of the disease.
Similar articles
-
Diagnostic accuracy of cytokine levels (TNF-alpha, IL-2 and IFN-gamma) in bronchoalveolar lavage fluid of smear-negative pulmonary tuberculosis patients.Respiration. 2008;75(1):73-8. doi: 10.1159/000110744. Epub 2007 Nov 1. Respiration. 2008. PMID: 17975298
-
Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil.Tuberculosis (Edinb). 2008 Sep;88(5):474-81. doi: 10.1016/j.tube.2008.06.002. Epub 2008 Jul 26. Tuberculosis (Edinb). 2008. PMID: 18676203
-
Decreased phosphorylation of STAT-1, STAT-4 and cytokine release in MDR-TB patients with primary resistance.Int J Tuberc Lung Dis. 2008 Sep;12(9):1071-6. Int J Tuberc Lung Dis. 2008. PMID: 18713507
-
Th22 response induced by Mycobacterium tuberculosis strains is closely related to severity of pulmonary lesions and bacillary load in patients with multi-drug-resistant tuberculosis.Clin Exp Immunol. 2021 Feb;203(2):267-280. doi: 10.1111/cei.13544. Epub 2020 Nov 18. Clin Exp Immunol. 2021. PMID: 33128773 Free PMC article. Review.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
Cited by
-
Clinical Efficacy of a Combination of Thymopentin and Antituberculosis Drugs in Treating Drug-Resistant Pulmonary Tuberculosis: Meta Analysis.Ther Clin Risk Manag. 2022 Mar 25;18:287-298. doi: 10.2147/TCRM.S351317. eCollection 2022. Ther Clin Risk Manag. 2022. PMID: 35386182 Free PMC article.
-
Latent Tuberculosis Patients Have an Increased Frequency of IFN-γ-Producing CD5+ B Cells, Which Respond Efficiently to Mycobacterial Proteins.Pathogens. 2023 Jun 9;12(6):818. doi: 10.3390/pathogens12060818. Pathogens. 2023. PMID: 37375508 Free PMC article.
-
Can immune parameters be used as predictors to distinguish between pulmonary multidrug-resistant and drug-sensitive tuberculosis?Arch Med Sci. 2010 Mar 1;6(1):77-82. doi: 10.5114/aoms.2010.13511. Epub 2010 Mar 9. Arch Med Sci. 2010. PMID: 22371724 Free PMC article.
-
Alterations in the peripheral blood B cell subpopulations of multidrug-resistant tuberculosis patients.Clin Exp Med. 2014 Nov;14(4):423-9. doi: 10.1007/s10238-013-0258-1. Epub 2013 Sep 26. Clin Exp Med. 2014. PMID: 24068613
-
A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis.PLoS One. 2017 May 2;12(5):e0176660. doi: 10.1371/journal.pone.0176660. eCollection 2017. PLoS One. 2017. PMID: 28464011 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous